News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Business
Incyte Corporation Posts Wider Q3 Loss on Research Costs
November 6, 2008
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
Nov 6 (Reuters) - Biotechnology company Incyte Corp posted a wider third-quarter loss, hurt by research and development costs that rose about 50 percent.
Twitter
LinkedIn
Facebook
Email
Print
Earnings
Incyte
MORE ON THIS TOPIC
Manufacturing
GSK Commits $30B To Boost US R&D, Manufacturing Operations
September 17, 2025
·
1 min read
·
Tristan Manalac
Manufacturing
Lilly to Bring Nearly 2,500 Jobs to Virginia With $5B Manufacturing Plant
September 17, 2025
·
1 min read
·
Tristan Manalac
Startups
Ollin Emerges From Stealth With $100M To Develop Eye Disease Bispecifics
September 17, 2025
·
2 min read
·
Tristan Manalac
Artificial Intelligence
The Future of Pharma Is Predictive Care Powered by Consumers, AI: PwC
September 17, 2025
·
2 min read
·
Annalee Armstrong
